Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV
Stable genetic incorporation and display of a functional heterologous glycoprotein into a SARS-CoV-2 virion are demonstrated, supporting use of the ΔE SARS-CoV-2 backbone as a potential platform for viral vector engineering and heterologous antigen delivery.